Arkolith/Insider Trading/LIXT/Form 4/A

Bernards Rene

DirectorLIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) · full profile →Form 4/A · filed Oct 5, 2023
Net Buying
Open-Market Buys
$24K
Open-Market Sells
$0
Net Open-Market Flow
$24K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 3, 2023Buy(P)6K$2.51$14K25K
Oct 2, 2023Buy(P)4K$2.29$10K19K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001493152-23-036424) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML